Zobrazeno 1 - 10
of 60
pro vyhledávání: '"B. Witteman"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G D'Haens, C Taxonera, A Lopez-Sanroman, P Nos Mateu, S Danese, A Armuzzi, X Roblin, L Peyrin-Biroulet, R West, B Witteman, M Duijvestein, K Gecse, M Hulshoff, N Mostafavi, E Clasquin, Y Bouhnik, D Laharie
Publikováno v:
Journal of Crohn's and Colitis. 17:i19-i19
Background Crohn’s disease (CD) is a chronic, immune-mediated inflammatory condition of the intestine, for which the majority of patients still needs to undergo surgical resection. Following the most common intervention ileocolonic resection, the v
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R Mahmoud, E Savelkoul, W Mares, R Goetgebuer, B Witteman, D de Koning, I Minderhoud, S van Tuyl, P van Boeckel, N Mahmmod, M Lutgens, C Horjus, T Römkens, D Akol-Simsek, J Jansen, F Hoentjen, B Jharap, B Oldenburg
Publikováno v:
Journal of Crohn's and Colitis. 16:i113-i114
Background Discontinuation of anti-tumour necrosis factor alpha agents (anti-TNF) in patients with inflammatory bowel disease (IBD) in remission may reduce side effects and costs, but this has to be weighed against the risk of relapse. We developed a
Background: There is a paucity of data comparing 30-day morbidity and mortality of sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and one anastomosis gastric bypass (OAGB). This study aimed to compare the 30-day safety of SG, RYGB, and OAG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a906be1d6fa8569c29cca2b4bba174a5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2987332
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2987332
Publikováno v:
ESGE Days.
Autor:
Jessica R. de Bruyn, Peter Bossuyt, Marc Ferrante, Rachel L. West, Gerard Dijkstra, Ben J. Witteman, Manon Wildenberg, Frank Hoentjen, Denis Franchimont, Esmé Clasquin, Jarmila D. van der Bilt, Tim Tollens, Willem A. Bemelman, Andre D’Hoore, Marjolijn Duijvestein, Geert R. D’Haens, W. Bemelman, C. Buskens, E. Clasquin, J. De Bruyn, G. D’Haens, M. Duijvestein, J. Van der Bilt, B. Ferreira, S. Mulder, R. West, G. Dijkstra, A. Engelsman, J. Lange, L. Homans, B. Witteman, A. Eroglu-Berger, M. Russel, J. Jansen, T. Schakel–van den Berge, S. Cuppen, F. Hoentjen, A. Van Esch, D.J. De Jong, N. Mahmmod, W. Ten Hove.P. De Lange, R. Mallant, P. Houben, M. Ferrante, S. Vermeire, A. Outtier, T. Hermans, J. Lefrère, A. D’Hoore, K. Asnong, P. Bossuyt, I. Van de Schoot, B. Claerbout, G. Lambrecht, L. Boutaffala, C. Guebelle, E. Louis, D. Franchimont, V. Wambacq, A. Colard, A. Deflandre
Publikováno v:
Clinical Gastroenterology and Hepatology, 19, 1573-1582.e5
Clinical Gastroenterology and Hepatology, 19, 8, pp. 1573-1582.e5
Clinical Gastroenterology and Hepatology, 19(8), 1573-1582.e5. ELSEVIER SCIENCE INC
Clinical gastroenterology and hepatology, 19(8), 1573-1582.e5. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 19, 8, pp. 1573-1582.e5
Clinical Gastroenterology and Hepatology, 19(8), 1573-1582.e5. ELSEVIER SCIENCE INC
Clinical gastroenterology and hepatology, 19(8), 1573-1582.e5. W.B. Saunders Ltd
BACKGROUND & AIMS: Vitamin D deficiency is common in Crohn's disease (CD). High-dose vitamin D had anti-inflammatory effects in preclinical studies and trials of patients with CD. We performed a randomized trial to determine whether high-dose vitamin
Autor:
Jerry M. Wells, Ben Meijer, M van Splunter, Esther G Floris-Vollenbroek, E. van Hoffen, R.J.J. van Neerven, Harro M. Timmerman, B Witteman, Huub F. J. Savelkoul, E Lucas-van de Bos, Sylvia Brugman, Laurien H. Ulfman
Publikováno v:
Mucosal Immunology, 11(4), 1254-1264
Mucosal Immunology 11 (2018) 4
Mucosal Immunology 11 (2018) 4
Oral cholera vaccination is used to induce immune responses in the intestines to protect against cholera infection. However, oral vaccination may also affect immune responses in other mucosal tissues. To study this, tissue-specific homing potential a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a7ce6211cb1aa57fc95e16dfe7b64b
https://research.wur.nl/en/publications/oral-cholera-vaccination-promotes-homing-of-iga-memory-b-cells-to
https://research.wur.nl/en/publications/oral-cholera-vaccination-promotes-homing-of-iga-memory-b-cells-to
Publikováno v:
Techniques in Coloproctology 20 (2016) 6
Techniques in Coloproctology, 20(6), 339-341
Techniques in coloproctology, 20(6), 339-341. Springer
Techniques in Coloproctology, 20(6), 339-341
Techniques in coloproctology, 20(6), 339-341. Springer
Editorial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49d05d62a62c6b04e5b7dc0f36d2183
https://research.wur.nl/en/publications/surgery-and-functional-mobility-doing-the-right-thing-at-the-righ
https://research.wur.nl/en/publications/surgery-and-functional-mobility-doing-the-right-thing-at-the-righ